Challenges and Opportunities in Head and Neck Cancer Research in Developing Countries: Insights From a Fireside Chat
- Chaves, Aline Lauda Freitas MD, MSc1,,
- Kowalski, Luiz Paulo MD, PhD2,
- Marta, Gustavo Nader MD, PhD3
- Santos-Silva, Alan Roger PhD, DDS, MSc4
- Vieira Muniz, Luciana MSc5
- Mak, Milena Perez MD, PhD6,
- Gossling, Gustavo MD7
- Guimaraes, Vítor Souza MD8
- Oliveira de Castro Junior, Dalvaro MD9,
- de Oliveira, Thiago Bueno MD, PhD10,
- Lima, Carmen Silvia Passos MD, PhD11
- Traldi Macedo, Ligia MD, PhD11,
- Jacinto, Alexandre Arthur MD, PhD12
- Harada, Guilherme MD13,
- Barbosa, Malu Viter da Rosa MD8,
- Santos, Izabella Costa MD, PhD14
- Batalha Filho, Eronides Salustiano MD15
- De Castro Junior, Gilberto MD, PhD16,
- de Marchi, Pedro Rafael Martins MD, PhD17,
- Matos, Leandro Luongo MD, PhD18,
- Curado, Maria Paula MD, PhD10
- Mehanna, Hisham MD, PhD19,
- William, William Nassib Jr MD8,
Head and neck squamous cell carcinoma (HNSCC) represents a significant public health burden in developing countries, where access to early diagnosis, comprehensive care, and research infrastructure is limited. This article synthesizes the insights generated during a Fireside Chat convened by members of the Latin American Cooperative Oncology Group (LACOG)—Head and Neck and the Brazilian Group of Head and Neck Cancer (GBCP), with the participation of international expert Professor Hisham Mehanna. The discussion addressed key challenges and opportunities in clinical and translational research within resource-constrained settings. Major themes included the unmet needs of patients with HNSCC, particularly regarding treatment-related toxicities and the need for biomarker-driven, personalized approaches. Barriers to research in low- and middle-income countries were explored, including patient comorbidities, late-stage presentation, and regulatory hurdles. The group emphasized the importance of pragmatic, context-sensitive research that reflects local disease burden, health care structures, and cultural factors. Capacity building, multidisciplinary teamwork, and integration of translational science into clinical care were highlighted as essential for advancing outcomes. The manuscript also outlines the preparedness of Brazilian centers for early-phase trials, strategies to enhance patient recruitment, and mechanisms to strengthen collaboration among researchers, governmental agencies, and industry. Successful models from LACOG and GBCP were presented to illustrate local leadership in advancing HNSCC research. Ultimately, the authors advocate for a coordinated national research agenda that positions Brazil and similar nations as meaningful contributors to the global head and neck cancer research landscape, fostering innovation while addressing the realities of under-represented populations.